RecruitingNot applicableNCT06224413

A Study of Participants With Cerebral Adrenoleukodystrophy (CALD) Treated With Elivaldogene Autotemcel

Studying Leukodystrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Genetix Biotherapeutics Inc.
Principal Investigator
Kiran Bhirangi, MD
bluebird bio, Inc.
Intervention
No Intervention(other)
Enrollment
120 enrolled
Eligibility
MALE
Timeline
20242047

Study locations (3)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06224413 on ClinicalTrials.gov

Other trials for Leukodystrophy

Additional recruiting or active studies for the same condition.

See all trials for Leukodystrophy

← Back to all trials